LANIAZID Drug Patent Profile
✉ Email this page to a colleague
When do Laniazid patents expire, and what generic alternatives are available?
Laniazid is a drug marketed by Lannett and Chartwell Molecular and is included in three NDAs.
The generic ingredient in LANIAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Laniazid
A generic version of LANIAZID was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LANIAZID?
- What are the global sales for LANIAZID?
- What is Average Wholesale Price for LANIAZID?
Summary for LANIAZID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 154 |
| Patent Applications: | 4,105 |
| DailyMed Link: | LANIAZID at DailyMed |
Pharmacology for LANIAZID
| Drug Class | Antimycobacterial |
US Patents and Regulatory Information for LANIAZID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | LANIAZID | isoniazid | SYRUP;ORAL | 089243-001 | Feb 3, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Molecular | LANIAZID | isoniazid | TABLET;ORAL | 089776-001 | Jun 13, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Molecular | LANIAZID | isoniazid | TABLET;ORAL | 080140-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Molecular | LANIAZID | isoniazid | TABLET;ORAL | 080140-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
